Progress in the active immunotherapeutic approach to Alzheimer's disease: Clinical investigations into AN1792-associated meningoencephalitis

Neurodegenerative Diseases

Volumn 5, Issue 3-4, 2008, Pages 194-196

  Pride, Michael ^a,b   Seubert, Peter ^b,c   Grundman, Michael ^b,c   Hagen, Michael ^a,b   Eldridge, John ^a,b   Black, Ronald S ^a,b  

^a PFIZER INC   (United States)

^b Elan Pharmaceuticals ^*

^c ELAN PHARMACEUTICALS   (United States)

Author keywords

Alzheimer's disease; Experimental therapies; Immunotherapy; Neuroinflammation; T cells; Amyloid protein

Indexed keywords

ALZHEIMER DISEASE VACCINE; CARRIER PROTEIN; CD4 ANTIGEN; EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYSORBATE 80;

ACTIVE IMMUNIZATION; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; BLOOD; CARBOXY TERMINAL SEQUENCE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONFERENCE PAPER; CONJUGATION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; HUMAN; IMMUNE RESPONSE; MENINGOENCEPHALITIS; MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TH1 CELL; TH2 CELL;

EID: 40449086748     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000113700     Document Type: Conference Paper

References (7)